Literature DB >> 2563226

Infectious complications of cyclophosphamide treatment for vasculitis.

J D Bradley1, K D Brandt, B P Katz.   

Abstract

Fifteen patients with Wegener's granulomatosis, polyarteritis nodosa, or isolated angiitis of the central nervous system were treated with cyclophosphamide according to a widely used regimen. Seventeen clinical episodes of infection were observed over 201 patient-months of cyclophosphamide therapy, and 2 patients died of pneumonia. Notably, neither the incidence of leukopenia nor the dosage or duration of cyclophosphamide or corticosteroid therapy correlated well with infection, which occurred most frequently in men over 60 years of age. Patients with Wegener's granulomatosis appeared to be at greater risk of infection than those with the other forms of vasculitis. These results suggest that this treatment regimen may not be as safe as was previously thought.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563226     DOI: 10.1002/anr.1780320108

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  17 in total

1.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro.

Authors:  B Hellmich; E Csernok; A Trabandt; W L Gross; M Ernst
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Churg-Strauss syndrome.

Authors:  M Conron; H L Beynon
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 3.  Pulmonary vasculitis.

Authors:  Kevin K Brown
Journal:  Proc Am Thorac Soc       Date:  2006

Review 4.  New horizons in renal vasculitis.

Authors:  J S Cameron
Journal:  Klin Wochenschr       Date:  1991-09-03

Review 5.  Central nervous system polyarteritis nodosa.

Authors:  M R Rosenberg; M Parshley; S Gibson; R Wernick
Journal:  West J Med       Date:  1990-11

Review 6.  Pulmonary vasculitis.

Authors:  A Burns
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

Review 7.  Optimisation of cyclophosphamide therapy in systemic vasculitis.

Authors:  R Richmond; T W McMillan; R A Luqmani
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

8.  Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis.

Authors:  B Godeau; J L Mainardi; F Roudot-Thoraval; E Hachulla; L Guillevin; L T Huong Du; B Jarrousse; P Remy; A Schaeffer; J C Piette
Journal:  Ann Rheum Dis       Date:  1995-12       Impact factor: 19.103

9.  CRP levels in autoimmune disease can be specified by measurement of procalcitonin.

Authors:  V Schwenger; J Sis; A Breitbart; K Andrassy
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

10.  Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.

Authors:  Francisco Silva; Ulrich Specks; Sanjay Kalra; Marie C Hogan; Nelson Leung; Sanjeev Sethi; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.